EGFR and breast carcinoma: Upon downregulation of Spry functions, e.g., when the Spry genes are knocked out in the mutant mammary glands or their functions are otherwise silenced in breast cancer, multiple pathways of RTK signaling, especially downstream of EGFR and IGFR, are increased.